Süalp Tansan, MD

Medical Oncologist | Founder, Tansan Oncology

Dr. Süalp Tansan is the founder of Tansan Oncology and a medical oncology specialist with over 30 years of experience in cancer treatment. He was born in Istanbul in 1959 and graduated from Istanbul University Faculty of Medicine in 1983.

Born in Istanbul in 1959, he graduated from Istanbul University Faculty of Medicine in 1983. After completing compulsory medical service in Turkey, he continued his postgraduate medical training in the United States, completing his residency in Internal Medicine and fellowship in Medical Oncology at Boston University Medical Center.

He passed the American Board of Internal Medicine examination in the 98th percentile. From 1991 to 1995, Dr. Tansan served as Director of the Chemotherapy Clinic and was involved in postgraduate specialty training at Boston University. During this period, he combined clinical oncology with medical education and scientific work. In recognition of his contributions to Boston University School of Medicine and its affiliated hospital, he received the Distinguished Physician Award for the 1991–1995 period. Dr. Tansan returned to Istanbul in 1995 and founded Tansan Oncology Center, establishing an independent clinical practice dedicated to contemporary medical oncology. Over the past 30 years, Tansan Oncology has provided more than 100,000 patient consultations and systemic cancer treatment sessions. Today, Dr. Tansan’s clinical work focuses particularly on patients with complex and advanced cancers and on the thoughtful application of precision oncology. His approach integrates established oncology practice with tumor molecular profiling, genomic testing, targeted therapies and immunotherapy when these are relevant to the clinical problem and supported by evidence.

His approach evaluates established oncology practices, along with molecular profiling of the tumor, genomic testing, targeted therapies, and immunotherapy, when clinically relevant. A key part of his core approach is the reassessment of treatment as cancer changes.

A central principle of his practice is that treatment should evolve as the disease evolves. Clinical response, imaging and molecular findings - including repeat tumor profiling or liquid biopsy when appropriate - are considered together when planning subsequent treatment. Dr. Tansan continues to follow developments in cancer biology, molecular diagnostics and systemic therapy closely, with the aim of translating clinically meaningful advances into well-considered treatment decisions for individual patients.

OUR TREATMENT METHODS

PRECISION ONCOLOGY AND MOLECULAR PROFILING

TOP